To be Equipped With Weapons for Future Strains of COVID-19

Since its first appearance in December 2019, scientists all over the world are working towards treatment for COVID-19.
We are happy to announce that Kcat Enzymatic is funded by the UKRI grant for in-vitro screening and validation of molecules to target spike protein a Mpro of COVID-19. The test is being carried out at the University of St. Andrews, United Kingdom for “Covalent modulators of the spike protein of COVID-19 and compounds that challenge the pockets that stabilize the interchain interaction of spike protein of COVID-19 and new covalent modulators against Mpro of Covid-19”